Press Releases & Articles

Kinnate Biopharma Appoints Dean J. Mitchell as Chairman of the Board

Kinnate Biopharma Closes $98 Million Series C Financing

Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer

Precision Oncology News: Kinnate Exiting Stealth Mode With Plans to Move Lead RAF Inhibitor Into Clinical Trials Next Year

Precision Oncology News: Kinnate Exiting Stealth Mode With Plans to Move Lead RAF Inhibitor Into Clinical Trials Next Year

Kinnate Biopharma Appoints Nima Farzan as Chief Executive Officer

Kinnate Biopharma Closes $74.5M Series B Financing

Fount Therapeutics Secures $22M Series A Financing